Emiko Takai

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Yoshito Itoh, Emiko Takai, Hiroyuki Ohnuma et al. · Proceedings of the National Academy of Sciences · 1986 · 243 citations · Full text

Vaccination, Protective Efficacy, Vaccine Development +14

Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis

Masahito Shimizu, Masami Ohyama, Y Takahashi et al. · Gastroenterology · 1983 · 81 citations

Immunohematology, Allergy, Hepatology +8

Low C3B receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody

Seiji Minota, Chihiro Terai, Yoshihisa Nojima et al. · Arthritis & Rheumatism · 1984 · 63 citations

Immunohematology, Laboratory Immunology, Immunology +18

Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection

Fumio Tsuda, Shigeko Naito, Emiko Takai et al. · Gastroenterology · 1984 · 48 citations

Vaccination, Hepatology, Low Molecular Weight +11

Polypeptides coded for by the region pre-S and gene S of hepatitis B virus DNA with the receptor for polymerized human serum albumin: expression on hepatitis B particles produced in the HBeAg or anti-HBe phase of hepatitis B virus infection.

Kazuo Takahashi, S Kishimoto, Hiroyuki Ohnuma et al. · The Journal of Immunology · 1986 · 45 citations · Full text

Immunology, Hepatitis B, Molecular Biology +18